E Kelly Callahan
Overview
Explore the profile of E Kelly Callahan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lynn M, Ayele Z, Chernet A, Goodhew E, Wickens K, Sata E, et al.
PLoS Negl Trop Dis
. 2025 Mar;
19(3):e0012900.
PMID: 40067808
Background: Persistent trachoma is increasingly recognized as a serious concern for the global trachoma program. Persistent trachoma is defined as those districts that have had two or more trachoma impact...
2.
Ohidor S, Presley N, Sanders A, Nute A, Gonzalez T, Bol Y, et al.
Trop Med Int Health
. 2025 Jan;
30(3):159-169.
PMID: 39788726
Background: Trachoma is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2030. Trachoma impact surveys using standardised methodology are recommended to monitor progress...
3.
Negash M, Tadesse Z, Ambaw F, Beka M, Belete T, Abte M, et al.
PLOS Ment Health
. 2024 Dec;
1(6):e0000191.
PMID: 39640254
Stigma is common in people affected with Neglected Tropical Diseases (NTDs). However, no validated tools are available to assess and monitor stigma in trachoma-affected communities. We tested the cross-cultural equivalence...
4.
Kamau E, Ante-Testard P, Gwyn S, Blumberg S, Abdalla Z, Aiemjoy K, et al.
medRxiv
. 2024 Oct;
PMID: 39399026
Trachoma is targeted for global elimination as a public health problem by 2030. Measurement of IgG antibodies in children is being considered for surveillance and programmatic decision-making. There are currently...
5.
Aragie S, Shiferaw A, Sata E, Hailu D, Dagnew A, Zeru T, et al.
Trop Med Int Health
. 2024 Aug;
29(10):869-874.
PMID: 39142662
Objectives: A 6-week course of tetracycline eye ointment is an alternative to single -dose oral azithromycin in annual mass drug administration for trachoma control. Compliance with the recommended tetracycline eye...
6.
Jesudason T, Sanders A, Ohidor S, Delahunt A, Deathe A, Boniface L, et al.
PLOS Glob Public Health
. 2024 Jul;
4(7):e0003242.
PMID: 39028729
Community-wide distribution of azithromycin, otherwise known as mass drug administration (MDA), is a component of the World Health Organization-endorsed SAFE strategy for the elimination of trachoma as a public health...
7.
Nash S, Sata E, Chernet A, Gonzalez T, Nute A, Ontiveros V, et al.
Am J Trop Med Hyg
. 2024 Jul;
111(3_Suppl):105-113.
PMID: 38955191
Persistent trachoma is a growing concern to trachoma control programs globally and programs serving Ethiopia specifically. Persistent trachoma is defined as a district with two or more trachoma impact surveys...
8.
Bromfield J, Aguwa U, Sata E, Jensen K, Mihretu F, Callahan E, et al.
Am J Trop Med Hyg
. 2024 Jun;
111(3_Suppl):121-126.
PMID: 38917786
Trachomatous scarring has been shown to progress regardless of active ocular Chlamydia trachomatis infection, indicating that scarring drivers may be unrelated to ongoing transmission. Although scarring prevalence is commonly associated...
9.
Harte A, Ghasemian E, Pickering H, Houghton J, Chernet A, Sata E, et al.
PLoS Negl Trop Dis
. 2024 Apr;
18(4):e0012143.
PMID: 38662795
Trachoma is the leading infectious cause of blindness worldwide and is now largely confined to around 40 low- and middle-income countries. It is caused by Chlamydia trachomatis (Ct), a contagious...
10.
Sata E, Seife F, Ayele Z, Murray S, Wickens K, Le P, et al.
PLoS Negl Trop Dis
. 2024 Feb;
18(2):e0011986.
PMID: 38386689
Background: Trachoma recrudescence after elimination as a public health problem has been reached is a concern for control programs globally. Programs typically conduct district-level trachoma surveillance surveys (TSS) ≥ 2...